Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 11 studies | 29% ± 12% | |
| endothelial cell | 10 studies | 22% ± 12% | |
| astrocyte | 5 studies | 40% ± 20% | |
| GABAergic neuron | 5 studies | 31% ± 16% | |
| capillary endothelial cell | 4 studies | 19% ± 2% | |
| smooth muscle cell | 4 studies | 21% ± 6% | |
| myofibroblast cell | 3 studies | 28% ± 4% | |
| GABAergic interneuron | 3 studies | 16% ± 1% | |
| epithelial cell | 3 studies | 43% ± 18% | |
| fibroblast | 3 studies | 22% ± 2% | |
| endothelial cell of artery | 3 studies | 27% ± 8% | |
| interneuron | 3 studies | 49% ± 21% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 92% | 247.45 | 420 / 459 | 62% | 1.53 | 692 / 1118 |
| brain | 47% | 62.29 | 1232 / 2642 | 92% | 4.26 | 650 / 705 |
| esophagus | 76% | 273.86 | 1100 / 1445 | 56% | 1.38 | 102 / 183 |
| bladder | 100% | 490.05 | 21 / 21 | 30% | 0.77 | 149 / 504 |
| intestine | 89% | 257.59 | 857 / 966 | 38% | 0.80 | 199 / 527 |
| uterus | 98% | 600.74 | 166 / 170 | 29% | 0.99 | 131 / 459 |
| stomach | 76% | 233.46 | 274 / 359 | 47% | 1.11 | 135 / 286 |
| lung | 95% | 380.37 | 547 / 578 | 28% | 0.64 | 326 / 1155 |
| ovary | 76% | 201.25 | 137 / 180 | 28% | 0.64 | 121 / 430 |
| spleen | 100% | 486.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 593.40 | 1322 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 94% | 321.49 | 1134 / 1204 | 0% | 0 | 0 / 0 |
| skin | 73% | 954.47 | 1314 / 1809 | 21% | 0.76 | 100 / 472 |
| prostate | 86% | 216.20 | 211 / 245 | 3% | 0.12 | 15 / 502 |
| adrenal gland | 65% | 85.34 | 168 / 258 | 20% | 0.40 | 45 / 230 |
| kidney | 78% | 142.96 | 69 / 89 | 6% | 0.18 | 50 / 901 |
| thymus | 77% | 132.20 | 502 / 653 | 6% | 0.09 | 36 / 605 |
| heart | 74% | 128.91 | 633 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 2.31 | 6 / 328 | 70% | 1.65 | 124 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 0.55 | 8 / 29 |
| liver | 15% | 15.88 | 35 / 226 | 9% | 0.15 | 35 / 406 |
| peripheral blood | 20% | 84.74 | 187 / 929 | 0% | 0 | 0 / 0 |
| muscle | 7% | 7.98 | 54 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0003279 | Biological process | cardiac septum development |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0001822 | Biological process | kidney development |
| GO_0035904 | Biological process | aorta development |
| GO_0060976 | Biological process | coronary vasculature development |
| GO_0006508 | Biological process | proteolysis |
| GO_0005576 | Cellular component | extracellular region |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0008237 | Molecular function | metallopeptidase activity |
| Gene name | ADAMTS6 |
| Protein name | A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-) ADAMTS6 variant 2 |
| Synonyms | |
| Description | |
| Accessions | Q5IR90 Q9UKP5 ENST00000381052.8 [Q9UKP5-4] ENST00000381055.8 [Q9UKP5-1] |